RANZCP homepage
Mark Horowitz
Profile
Dr Mark Horowitz
Dr Mark Horowitz MBBS PhD is a Clinical Research Fellow in Psychiatry in the National Health Service (NHS) in England, Visiting Lecturer in Psychopharmacology at King’s College London, and a trainee psychiatrist.
He has a PhD from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London in the neurobiology of depression and antidepressant action.
He is the lead author of the Maudsley Deprescribing Guidelines, which provides the basis for national guidance in the UK from the NHS for prescribers on how to safely stop psychiatric drugs and has been endorsed by the RACGP in Australia, and the Royal Pharmaceutical Society in the UK.
Dr Mark Horowitz MBBS PhD is a Clinical Research Fellow in Psychiatry in the National Health Service (NHS) in England, Visiting Lecturer in Psychopharmacology at King’s College London, and a trainee psychiatrist.
He has a PhD from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London in the neurobiology of depression and antidepressant action.
He is the lead author of the Maudsley Deprescribing Guidelines, which provides the basis for national guidance in the UK from the NHS for prescribers on how to safely stop psychiatric drugs and has been endorsed by the RACGP in Australia, and the Royal Pharmaceutical Society in the UK.
